Key result
Severe acidosis attenuated the positive inotropic effects of milrinone in both in vivo canine and in vitro guinea pig models, likely due to decreased cAMP formation.
Why the study?
Does acidosis attenuate the cardiotonic effects of milrinone in animal models?
Does acidosis attenuate the cardiotonic effects of milrinone in animal models?
Acidosis significantly attenuates the positive inotropic effects of milrinone, likely due to impaired cAMP formation in acidotic muscle.
May blunt milrinone efficacy in acidotic patients; leaves open human translation of these animal findings.
BACKGROUND: The present study was designed to determine whether augmentation of cardiac performance by milrinone is affected by acidosis in in vivo canine and in vitro guinea pig preparations, and to elucidate a mechanism in relation to the cyclic adenosine monophosphate (cAMP) formation. METHODS: Halothane-anesthetized, ventilated dogs were randomly assigned to a control group (arterial pH [pHa] approximately 7.4, base excess [BE] > -2 mM; n = 7), mild acidosis group (pHa approximately 7.2, BE < -9 mM; n = 7); or severe acidosis group (pHa < 7, BE < -20 mM; n = 6). Arterial blood pressure, left ventricular pressure (including maximum rate of increase, LV dP/dtmax), and pulmonary blood flow (PBF) were measured. Acidosis was induced by transient hypoxia and maintained with hydrogen chloride infusion. Hemodynamic responses to milrinone infusions at 2 and 5 microg x kg(-1) x min(-1) were then studied. In addition, left atria and right ventricular strips were dissected from guinea pig hearts and suspended in HEPES-Tyrode solution, with pH values adjusted to 7.4, 7, or 6.6. The concentration-response relation of isometric contractions for milrinone (10(-7) to 10(-4) M) and 8-bromo-cAMP (10(-4) to 10(-3) M) were determined. RESULTS: In the control group of dogs, significant increases in LV dP/dtmax (2,674 +/- 822 to 3,999 +/- 1,016 mmHg/s [means +/- SD]) and PBF (2.04 +/- 0.98 to 2.44 +/- 0.96 l/min [means +/- SD]) were seen with a milrinone infusion of 5 microg x kg(-1) x min(-1). In the mild acidosis group, 5 microg x kg(-1) x min(-1) milrinone also increased LV dP/dtmax and PBF. However, neither LV dP/dtmax nor PBF changed in the severe acidosis group. In in vitro experiments, milrinone exerted a positive inotropic effect in a concentration-dependent manner on the right ventricular preparations at pH 7.4, but not at pH 7 and 6.6, whereas no significant difference was observed in inotropic responses to 8-bromo-cAMP at pH values of 6.6, 7, and 7.4 on the right ventricular strips. In the right ventricular in vitro preparation, 10(-4) M milrinone was accompanied by a significant increase in intracellular cAMP content at apH of 7.4 but not 7. CONCLUSIONS: These results indicate that the inotropic effect of milrinone is attenuated by acidosis due, at least in part, to decreased cAMP formation in acidotic muscle.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (1998) studied Acidosis (n=20). Milrinone vs. Control group (pHa ~7.4) vs mild acidosis vs severe acidosis was evaluated on Hemodynamic responses (LV dP/dtmax and pulmonary blood flow). Severe acidosis attenuated the positive inotropic effects of milrinone in both in vivo canine and in vitro guinea pig models, likely due to decreased cAMP formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: